Lataa...
Drug repurposing for COVID-19: Approaches, challenges and promising candidates
Traditional drug development and discovery has not kept pace with threats from emerging and re-emerging diseases such as Ebola virus, MERS-CoV and more recently, SARS-CoV-2. Among other reasons, the exorbitant costs, high attrition rate and extensive periods of time from research to market approval...
Tallennettuna:
| Julkaisussa: | Pharmacol Ther |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier Inc.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8220862/ https://ncbi.nlm.nih.gov/pubmed/34174275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2021.107930 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|